Next-generation sequencing
Next-generation sequencing

Unlock the potential of (NGS) next-generation sequencing

Impactful discoveries powered by NGS

Next-generation sequencing (NGS) can deliver unprecedented insights, unraveling the intricacies of the genome and transcriptome in biomarker research, gene expression studies, viral epidemiology and disease surveillance, as well as comprehensive genomic profiling to identify variants implicated in cancer and other diseases. However, challenges such as workflow optimization, customization and data analysis and interpretation can hinder progress. Partner with QIAGEN to unlock the full potential of NGS with innovative QIAseq technologies.

With QIAseq, you can access the most difficult regions of the genome and derive impactful insights from the toughest of samples.
  • FFPE and liquid biopsy samples
  • Limited DNA and RNA samples
  • GC-rich regions
  • Low-frequency variants
  • Exonic regions
Genomics, QIAseq NGS Solutions, Dr. Mette Christiansen, Aarhus University hospital, COVID-1
Automate and accelerate your library prep
Automating your NGS means more consistency between runs, less batch processing errors, fewer re-runs, plus significant time and cost savings.

Enhance your core facility offering

Learn how we partner with core labs and shared facilities worldwide and provide products and services to support cutting-edge research.

two scientist in front of a monitor
Did you know?
QIAseq NGS products have been featured in >3000 publications in just the past four years.
Comprehensive miRNA sequencing for biomarker discovery

miRNAs are small, single-stranded, non-coding RNA molecules that regulate gene expression mainly by degrading messenger RNA or impeding translation, which can change protein levels. Next-generation sequencing technologies are rapidly advancing knowledge of miRNAs by analyzing both the expression and sequence of miRNAs in any tissue or sample type, even if they are present in very low amounts. It can also screen for miRNAs without prior knowledge of their sequence. There is mounting evidence now that miRNAs make ideal biomarkers of disease.

Camila Hochman-Mendez
Go from RNA-seq to gene expression insights with ease

Struggling to make sense of your RNA-seq data? Take the stress out of data analysis and fast-track your path to gene expression insights with the new RNA-seq Analysis Portal. Designed for biologists and fully integrated with GeneGlobe, this intuitive, web-based solution is now included with QIAseq RNA-seq and miRNA-seq kits. Simply upload your sequence files into the RNA-seq Analysis Portal, start your analysis and go from FASTQ files to focused insights into the top 10 canonical pathways, upstream regulators and diseases using powerful IPA knowledge bases.

Expanding disease insights with exome sequencing

The coding portion of the genome holds tantalizing information on multiple diseases. Unlocking these details through exome sequencing can reveal powerful insights into disease-associated variants. However, coverage issues, long turnaround times and data analysis bottlenecks can diminish progress. Explore a time-saving workflow that seamlessly combines uniform exome coverage with streamlined secondary analysis, rapid variant filtering and annotation.

Explore benefits of QIAseq NGS
Get in touch to see how QIAseq NGS solutions can transform your research.
woman infront of a touchscreen
Accelerate integrated insights from NGS data with maximum ease
You’ve run your benchtop experiment and finally achieved NGS data. But what does it all mean? Demystify data analysis and interpretation with our intuitive bioinformatics tools.

Useful resources to fuel your research

Woman in lab smiling

Meet the recipients of the 2021 QIAGEN RNA-seq Grant

In 2021, we invited researchers to explore the potential of RNA-seq for their research by applying for a QIAGEN RNA-seq Grant. We received an astounding 2400 applications and are pleased to announce the grant recipients.
All photos taken prior to COVID-19